Nexalin Technology, Inc. — Form SCHEDULE 13D
Filed September 3, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 32/100
What the filing says
Greenlight Ventures, LLC (NC-incorporated entity, EIN 81-5250164) filed a Schedule 13D on September 3, 2026, indicating acquisition of beneficial ownership in Nexalin Technology, Inc. (a $14.7M public company in electromedical apparatus). The filing document itself contains no disclosed share count, percentage ownership, dollar amount, or specific transaction details in the provided text—only administrative filing metadata and entity addresses.
Why this rating
No material transaction details disclosed in filing text; cannot assess ownership % or deal size. Routine 13D announcement likely routine disclosure absent concrete numbers or control threshold breach.
See more from September 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.